GPR43 positive allosteric modulators (Amgen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGPR43 positive allosteric modulators (Amgen)
Drug Alias Namephenylacetamide-based fatty acid receptor FFA2 positive allosteric modulators (Amgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 2 modulators
TargetsFree fatty acid receptor 2
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A